Recent innovations in pre-pregnancy and prenatal screening are helping to address health disparities and leading to more equitable care.
During the COVID-19 pandemic, more clinicians than ever are turning to telehealth. But one group of providers has been seeing patients virtually for years: genetic counselors.
In the midst of COVID-19, pregnant women and new moms are being forced to confront unexpected challenges and possible worst-case scenarios about delivery and the postpartum period.
Some of screening and diagnostic tests for women are woefully outdated or nonexistent, resulting in uncertainties about their disease risk and difficulty with diagnosis.
COVID-19 testing is a crucial element in the fight to end disease spread and may be of particular relevance for women, who tend to fill roles that increase their risk of exposure to the virus.
With most of the world facing restrictions on movement due to the novel coronavirus, many media outlets are reporting on both expected and observed increases in domestic violence cases globally.
Understanding the complicated world of screening and diagnostic testing can help patients better grasp the possibilities for their care.
Most women will never be screened for ovarian cancer. Unlike with breast and cervical cancers, ovarian cancer research has struggled to produce reliable methods of screening.